Evidence map›Paper›PMID 37489137›Full record

ArticleSAGE open medicine2023

Association of ABO blood types and clinical variables with COVID-19 infection severity in Libya.

Sara A Abdulla, Hayam A Elawamy, Negia Ae Mohamed, Enas H Abduallah, Habsa Aa Amshahar, Nadir K Abuzaeid, Mohamed Am Eisa, Makarim Elfadil M Osman, Emadeldin Hassan E Konozy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sara A AbdullaDepartment of Biochemistry, Faculty of Medicine, University of Benghazi, Benghazi, Libya.
Hayam A ElawamyCollege of Medical Technology, Benghazi, Libya.
Negia Ae MohamedDepartment of Biochemistry, Faculty of Medicine, University of Benghazi, Benghazi, Libya.
Enas H AbduallahDepartment of Mathematics, Faculty of Science, University of Tobruk, Tobruk, Libya.
Habsa Aa AmshaharDepartment of Pathology, Faculty of Medicine, Sirte University, Sirte, Libya.
Nadir K AbuzaeidDepartment of Medical Microbiology, Faculty of Medical Laboratory of Sciences, Omdurman Islamic University, Khartoum, Sudan.
Mohamed Am EisaDepartment of Physiology, Al Qunfudah Medical College, Umm Al Qura University, Al Qunfudah, Saudi Arabia.
Makarim Elfadil M OsmanLaboratory of Proteomics and Glycoproteins, Biotechnology Park, Africa City of Technology, Khartoum, Sudan.ORCID https://orcid.org/0000-0001-6619-6999
Emadeldin Hassan E KonozyLaboratory of Proteomics and Glycoproteins, Biotechnology Park, Africa City of Technology, Khartoum, Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The continuing COVID-19 pandemic is a coronavirus-related health emergency (severe acute respiratory syndrome coronavirus 2). Inadequate efforts are still being made to address the illness situation in Libya, and this must change. To address these issues, we looked into the demography and trend of the disease as well as the potential risk factors for infection. Methods: This study is a retrospective case-control study conducted online among 616 COVID-19 patients. The Results: Males were at high risk of COVID-19 than females (odds ratio = 1.3, 95% confidence interval: 1.042-1.622; Conclusion: This study provided for the first time the demographic data and the trend of COVID-19 infection in Libya, which will assist the stakeholders and governmental bodies in planning protection strategies against the pandemic.

Indexed as

case–control studychronic diseasesCOVID-19demographic dataLibyaquestionnaire

Identifiers

PMID37489137
PMCPMC10363681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.